In 2019, China National Pharmaceutical Group (Sinopharm) was the largest varicella (chickenpox) vaccine manufacturer in China, accounting for 39 percent of the total lot released volume. Measles, mumps and rubella are common respiratory infectious diseases among children. As varicella vaccine was not included into the category one, which is managed by the Chinese government and free-of-charge, the coverage rate of varicella vaccine in China was relatively lower than in other developed countries.
Market share of major varicella vaccine manufacturers in China in 2019, based on lot release volume
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Measures health care professionals feel would encourage public vaccination U.S. 2016
- Basic vaccines: global coverage rate 2007
- Opinions on the importance of vaccines according to U.S. adults 2018 vs 2020
- Italy: opinion about mandatory vaccination 2015 and 2017
- Share of worldwide human vaccine imports and exports in 2015, by country
- Trust in vaccines in France 2018
- Hungary: opinion on the effectiveness of vaccines to prevent infectious diseases 2019
- Total DTaP vaccination market size in China 2017-2030
- Survey on the safety of vaccines for healthy children in 2015
- Total DTcP and combined vaccination market size in China 2017-2030
- Austria: opinion on the effectiveness of vaccines to prevent infectious diseases 2019
- Total meningococcal vaccination public market size in China 2017-2030
- Meningitis C: vaccination coverage among infants in Spain 2006-2018
- Total meningococcal vaccination market size in China 2017-2030
- Frequency of taking dietary supplements in Singapore 2020, by gender
- Hong Kong: pre-purchase offline research sources 2015
- Rubber and plastic products manufacturing value added in the Philippines 2009-2018
- Change in peak power demand in Uttar Pradesh India FY 2016-2020
- Health functional foods domestic sales volume South Korea 2014-2019
Forward Intelligence (Qianzhan). (June 30, 2020). Market share of major varicella vaccine manufacturers in China in 2019, based on lot release volume [Graph]. In Statista. Retrieved March 09, 2021, from https://www.statista.com/statistics/1191749/china-market-share-of-major-varicella-vaccine-manufacturers/
Forward Intelligence (Qianzhan). "Market share of major varicella vaccine manufacturers in China in 2019, based on lot release volume." Chart. June 30, 2020. Statista. Accessed March 09, 2021. https://www.statista.com/statistics/1191749/china-market-share-of-major-varicella-vaccine-manufacturers/
Forward Intelligence (Qianzhan). (2020). Market share of major varicella vaccine manufacturers in China in 2019, based on lot release volume. Statista. Statista Inc.. Accessed: March 09, 2021. https://www.statista.com/statistics/1191749/china-market-share-of-major-varicella-vaccine-manufacturers/
Forward Intelligence (Qianzhan). "Market Share of Major Varicella Vaccine Manufacturers in China in 2019, Based on Lot Release Volume." Statista, Statista Inc., 30 Jun 2020, https://www.statista.com/statistics/1191749/china-market-share-of-major-varicella-vaccine-manufacturers/
Forward Intelligence (Qianzhan), Market share of major varicella vaccine manufacturers in China in 2019, based on lot release volume Statista, https://www.statista.com/statistics/1191749/china-market-share-of-major-varicella-vaccine-manufacturers/ (last visited March 09, 2021)